We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEN
2676
DELISTED
Genesis Healthcare, Inc.
GEN
$1.02M ﹤0.01%
623,336
-12,346
-2% -$18.5K
REX icon
2677
REX American Resources
REX
$1.41B
$1.02M ﹤0.01%
74,538
-59,592
-44% -$824K
INWK
2678
DELISTED
InnerWorkings, Inc.
INWK
$1.02M ﹤0.01%
184,544
-1,960
-1% -$9.5K
JAX
2679
DELISTED
J. Alexander's Holdings, Inc.
JAX
$1.01M ﹤0.01%
106,174
-5,752
-5% -$58.1K
NRIM icon
2680
Northrim BanCorp
NRIM
$587M
$1.01M ﹤0.01%
105,752
FARM
2681
DELISTED
Farmer Brothers
FARM
$1.01M ﹤0.01%
66,972
+25,728
+62% +$375K
EMWP
2682
DELISTED
Eros Media World PLC
EMWP
$1.01M ﹤0.01%
14,829
+2,504
+20% +$117K
HMTV
2683
DELISTED
Hemisphere Media Group, Inc.
HMTV
$1M ﹤0.01%
67,554
-5,122
-7% -$66.8K
INBK icon
2684
First Internet Bancorp
INBK
$255M
$1M ﹤0.01%
42,224
-180
-0.4% -$4.09K
HBCP icon
2685
Home Bancorp
HBCP
$566M
$998K ﹤0.01%
25,480
GBLI icon
2686
Global Indemnity Group
GBLI
$997K ﹤0.01%
33,676
-241
-0.7% -$6.41K
INSG icon
2687
Inseego
INSG
$90.5M
$997K ﹤0.01%
13,610
+2,228
+20% +$129K
KIN
2688
DELISTED
Kindred Biosciences, Inc.
KIN
$997K ﹤0.01%
117,628
-1,485
-1% -$11.6K
SMBC icon
2689
Southern Missouri Bancorp
SMBC
$850M
$991K ﹤0.01%
25,840
-259
-1% -$9.58K
WNEB icon
2690
Western New England Bancorp
WNEB
$275M
$990K ﹤0.01%
102,792
MLNX
2691
DELISTED
Mellanox Technologies, Ltd.
MLNX
$988K ﹤0.01%
+8,432
New +$958K
TBNK
2692
DELISTED
Territorial Bancorp Inc.
TBNK
$981K ﹤0.01%
31,699
ALBO
2693
DELISTED
Albireo Pharma Inc
ALBO
$978K ﹤0.01%
38,467
-446
-1% -$8.92K
VRA icon
2694
Vera Bradley
VRA
$98.7M
$977K ﹤0.01%
82,793
-345,640
-81% -$3.83M
SYRS
2695
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$972K ﹤0.01%
14,063
+3,299
+31% +$200K
SB icon
2696
Safe Bulkers
SB
$774M
$969K ﹤0.01%
570,390
-453,648
-44% -$788K
VRAY
2697
DELISTED
ViewRay, Inc.
VRAY
$968K ﹤0.01%
229,385
-26,662
-10% -$86.2K
TBIO
2698
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$958K ﹤0.01%
117,667
-335
-0.3% -$3.09K
MTEM
2699
DELISTED
Molecular Templates, Inc.
MTEM
$951K ﹤0.01%
4,537
+1,382
+44% +$199K
MNOV icon
2700
MediciNova
MNOV
$66M
$950K ﹤0.01%
141,061

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.